Anna-Katharina Wirth MS

Helmholtz Zentrum Munich

Appearances

Short Talk: Modelling Acquired Treatment Resistance in PDX ALL in vivo Reveals Identical Therapeutic Targets Regardless of Diverse Genomic Alterations
Date
April 22, 2021
Speaker
Anna-Katharina Wirth, MS
Helmholtz Zentrum Munich
Hematologic Malignancies
Date
April 22, 2021
Co-Chairs
Daniel Starczynowski, PhD
Cincinnati Children's Hospital Medical Center
Ross L. Levine, MD
Memorial Sloan Kettering Cancer Center
Speakers
Michael G. Kharas, PhD
Memorial Sloan Kettering Cancer Center
Iannis Aifantis, PhD
New York University School of Medicine
Anna-Katharina Wirth, MS
Helmholtz Zentrum Munich
Jing Fang, MD, PhD
University of South Carolina
Amitava Sengupta, PhD
Indian Institute of Chemical Biology

Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.